387 related articles for article (PubMed ID: 36161303)
1. Development of variant-proof severe acute respiratory syndrome coronavirus 2, pan-sarbecovirus, and pan-β-coronavirus vaccines.
Zhou J; Liu Z; Zhang G; Xu W; Xing L; Lu L; Wang Q; Jiang S
J Med Virol; 2023 Jan; 95(1):e28172. PubMed ID: 36161303
[TBL] [Abstract][Full Text] [Related]
2. Inactivated SARS-CoV-2 Vaccine Shows Cross-Protection against Bat SARS-Related Coronaviruses in Human ACE2 Transgenic Mice.
Liu MQ; Jiang RD; Guo J; Chen Y; Yang DS; Wang X; Lin HF; Li A; Li B; Hu B; Wang ZJ; Yang XL; Shi ZL
J Virol; 2022 Apr; 96(8):e0016922. PubMed ID: 35343762
[TBL] [Abstract][Full Text] [Related]
3. A pan-sarbecovirus vaccine based on RBD of SARS-CoV-2 original strain elicits potent neutralizing antibodies against XBB in non-human primates.
Liu Z; Zhou J; Wang X; Xu W; Teng Z; Chen H; Chen M; Zhang G; Wang Y; Huang J; Wang Q; Jiang S; Lu L
Proc Natl Acad Sci U S A; 2023 Mar; 120(11):e2221713120. PubMed ID: 36897979
[TBL] [Abstract][Full Text] [Related]
4. Broad Sarbecovirus Neutralizing Antibodies Obtained by Computational Design and Synthetic Library Screening.
Yang X; Duan H; Liu X; Zhang X; Pan S; Zhang F; Gao P; Liu B; Yang J; Chi X; Yang W
J Virol; 2023 Jul; 97(7):e0061023. PubMed ID: 37367229
[TBL] [Abstract][Full Text] [Related]
5. A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs.
Liu Z; Zhou J; Xu W; Deng W; Wang Y; Wang M; Wang Q; Hsieh M; Dong J; Wang X; Huang W; Xing L; He M; Tao C; Xie Y; Zhang Y; Wang Y; Zhao J; Yuan Z; Qin C; Jiang S; Lu L
Cell Res; 2022 Mar; 32(3):269-287. PubMed ID: 35046518
[TBL] [Abstract][Full Text] [Related]
6. Design of a bifunctional pan-sarbecovirus entry inhibitor targeting the cell receptor and viral fusion protein.
Jin H; Cheng L; Gong Y; Zhu Y; Chong H; Zhang Z; He Y
J Virol; 2023 Aug; 97(8):e0019223. PubMed ID: 37578234
[TBL] [Abstract][Full Text] [Related]
7. Vaccine-mediated protection against Merbecovirus and Sarbecovirus challenge in mice.
Martinez DR; Schäfer A; Gavitt TD; Mallory ML; Lee E; Catanzaro NJ; Chen H; Gully K; Scobey T; Korategere P; Brown A; Smith L; Parks R; Barr M; Newman A; Bowman C; Powers JM; Soderblom EJ; Mansouri K; Edwards RJ; Baric RS; Haynes BF; Saunders KO
Cell Rep; 2023 Oct; 42(10):113248. PubMed ID: 37858337
[TBL] [Abstract][Full Text] [Related]
8. A Cocktail of Lipid Nanoparticle-mRNA Vaccines Broaden Immune Responses against β-Coronaviruses in a Murine Model.
Zhang Y; Zhang J; Li D; Mao Q; Li X; Liang Z; He Q
Viruses; 2024 Mar; 16(3):. PubMed ID: 38543849
[TBL] [Abstract][Full Text] [Related]
9. A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.
Zhang J; Han ZB; Liang Y; Zhang XF; Jin YQ; Du LF; Shao S; Wang H; Hou JW; Xu K; Lei W; Lei ZH; Liu ZM; Zhang J; Hou YN; Liu N; Shen FJ; Wu JJ; Zheng X; Li XY; Li X; Huang WJ; Wu GZ; Su JG; Li QM
Elife; 2022 Aug; 11():. PubMed ID: 36004719
[TBL] [Abstract][Full Text] [Related]
10. Pan-Sarbecovirus Neutralizing Antibodies in BNT162b2-Immunized SARS-CoV-1 Survivors.
Tan CW; Chia WN; Young BE; Zhu F; Lim BL; Sia WR; Thein TL; Chen MI; Leo YS; Lye DC; Wang LF
N Engl J Med; 2021 Oct; 385(15):1401-1406. PubMed ID: 34407341
[TBL] [Abstract][Full Text] [Related]
11. Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice.
Martinez DR; Schäfer A; Leist SR; De la Cruz G; West A; Atochina-Vasserman EN; Lindesmith LC; Pardi N; Parks R; Barr M; Li D; Yount B; Saunders KO; Weissman D; Haynes BF; Montgomery SA; Baric RS
Science; 2021 Aug; 373(6558):991-998. PubMed ID: 34214046
[TBL] [Abstract][Full Text] [Related]
12. Broad-Spectrum Anti-coronavirus Vaccines and Therapeutics to Combat the Current COVID-19 Pandemic and Future Coronavirus Disease Outbreaks.
Cao M; Su X; Jiang S
Stem Cell Reports; 2021 Mar; 16(3):398-411. PubMed ID: 33691145
[TBL] [Abstract][Full Text] [Related]
13. Fc-mediated pan-sarbecovirus protection after alphavirus vector vaccination.
Adams LE; Leist SR; Dinnon KH; West A; Gully KL; Anderson EJ; Loome JF; Madden EA; Powers JM; Schäfer A; Sarkar S; Castillo IN; Maron JS; McNamara RP; Bertera HL; Zweigert MR; Higgins JS; Hampton BK; Premkumar L; Alter G; Montgomery SA; Baxter VK; Heise MT; Baric RS
Cell Rep; 2023 Apr; 42(4):112326. PubMed ID: 37000623
[TBL] [Abstract][Full Text] [Related]
14. Modular adjuvant-free pan-HLA-DR-immunotargeting subunit vaccine against SARS-CoV-2 elicits broad sarbecovirus-neutralizing antibody responses.
Kassardjian A; Sun E; Sookhoo J; Muthuraman K; Boligan KF; Kucharska I; Rujas E; Jetha A; Branch DR; Babiuk S; Barber B; Julien JP
Cell Rep; 2023 Apr; 42(4):112391. PubMed ID: 37053069
[TBL] [Abstract][Full Text] [Related]
15. Characterization of cross-reactive monoclonal antibodies against SARS-CoV-1 and SARS-CoV-2: Implication for rational design and development of pan-sarbecovirus vaccines and neutralizing antibodies.
Li S; Wu J; Jiang W; He H; Zhou Y; Wu W; Gao Y; Xie M; Xia A; He J; Zhang Q; Han Y; Wang N; Zhu G; Wang Q; Zhang Z; Mayer CT; Wang K; Wang X; Wang J; Chen Z; Jiang S; Sun L; Xia R; Wang Q
J Med Virol; 2023 Feb; 95(2):e28440. PubMed ID: 36573441
[TBL] [Abstract][Full Text] [Related]
16. Neutralizing monoclonal antibodies elicited by mosaic RBD nanoparticles bind conserved sarbecovirus epitopes.
Fan C; Cohen AA; Park M; Hung AF; Keeffe JR; Gnanapragasam PNP; Lee YE; Gao H; Kakutani LM; Wu Z; Kleanthous H; Malecek KE; Williams JC; Bjorkman PJ
Immunity; 2022 Dec; 55(12):2419-2435.e10. PubMed ID: 36370711
[TBL] [Abstract][Full Text] [Related]
17. A bivalent vaccine containing D614G and BA.1 spike trimer proteins or a BA.1 spike trimer protein booster shows broad neutralizing immunity.
Du P; Li N; Xiong X; Tang S; Dai Q; Liu Z; Wang T; Gu X; Zhou Z
J Med Virol; 2022 Sep; 94(9):4287-4293. PubMed ID: 35614524
[TBL] [Abstract][Full Text] [Related]
18. An interferon-integrated mucosal vaccine provides pan-sarbecovirus protection in small animal models.
Yuen CK; Wong WM; Mak LF; Lam JY; Cheung LY; Cheung DT; Ng YY; Lee AC; Zhong N; Yuen KY; Kok KH
Nat Commun; 2023 Oct; 14(1):6762. PubMed ID: 37875475
[TBL] [Abstract][Full Text] [Related]
19. Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity.
Jensen JL; Sankhala RS; Dussupt V; Bai H; Hajduczki A; Lal KG; Chang WC; Martinez EJ; Peterson CE; Golub ES; Rees PA; Mendez-Rivera L; Zemil M; Kavusak E; Mayer SV; Wieczorek L; Kannan S; Doranz BJ; Davidson E; Yang ES; Zhang Y; Chen M; Choe M; Wang L; Gromowski GD; Koup RA; Michael NL; Polonis VR; Rolland M; Modjarrad K; Krebs SJ; Joyce MG
J Virol; 2023 Jul; 97(7):e0159622. PubMed ID: 37395646
[TBL] [Abstract][Full Text] [Related]
20. Targeted isolation of diverse human protective broadly neutralizing antibodies against SARS-like viruses.
He WT; Musharrafieh R; Song G; Dueker K; Tse LV; Martinez DR; Schäfer A; Callaghan S; Yong P; Beutler N; Torres JL; Volk RM; Zhou P; Yuan M; Liu H; Anzanello F; Capozzola T; Parren M; Garcia E; Rawlings SA; Smith DM; Wilson IA; Safonova Y; Ward AB; Rogers TF; Baric RS; Gralinski LE; Burton DR; Andrabi R
Nat Immunol; 2022 Jun; 23(6):960-970. PubMed ID: 35654851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
